NX Quanex Building Products
Quanex Building Products earnings company data as of 4:49 AM ET 10/22
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q4 | 10 Dec | EPS | 0.79 | — | — |
| Rev | — | — | — | ||
| FY2026 Q3 | 3 Sep | EPS | 0.68 | 0.58 | Miss -14.7% |
| Rev | — | $501.8M | — |
Insider trades
Open-market buys and sales by NX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $3.2M sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Teleios Capital Partners GmbH 10% owner, +2 joint filersSale$3.2M 200,000 shares at $16.17 4.3% of stakeTraded Dec 16–17 Filed Dec 18, 2025
Also filed in the last 12 months, not counted as buying or selling: 6 stock grants, 4 share withholdings for taxes, 1 sale back to the company, and 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 21 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.03,5.07,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | FORM DEF 14A | Filing Doc | |
| 8-K | 4.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.